Development of a subunit vaccine containing recombinant Riemerella anatipestifer outer membrane protein A and CpG ODN adjuvant

Vaccine

Volumn 33, Issue 1, 2015, Pages 92-99

  Chu, Chun Yen ^a   Liu, Chia Hui ^a   Liou, Jhong Jie ^a   Lee, Jai Wei ^a   Cheng, Li Ting ^a  

^a NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

CpG adjuvant; Duck; OmpA; Riemerella anatipestifer; Subunit vaccine

Indexed keywords

BACTERIAL VACCINE; CPG OLIGODEOXYNUCLEOTIDE; CPG OLIGODEOXYNUCLEOTIDE VACCINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 6; MESSENGER RNA; OUTER MEMBRANE PROTEIN A; RECOMBINANT RIEMERELLA ANATIPESTIFER OUTER MEMBRANE PROTEIN A VACCINE; SODIUM CHLORIDE; SUBUNIT VACCINE; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; CPG-OLIGONUCLEOTIDE; CYTOKINE; IMMUNOLOGICAL ADJUVANT; OLIGODEOXYRIBONUCLEOTIDE; OMPA OUTER MEMBRANE PROTEINS; OUTER MEMBRANE PROTEIN; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; FLAVOBACTERIACEAE; FLAVOBACTERIACEAE INFECTION; IMMUNE RESPONSE; IMMUNIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMID; RIEMERELLA ANATIPESTIFER INFECTION; SCORING SYSTEM; T LYMPHOCYTE; TH1 CELL; TH2 CELL; ANIMAL; BIOSYNTHESIS; BLOOD; DUCK; FLAVOBACTERIACEAE INFECTIONS; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; PATHOLOGY; POULTRY DISEASES; RIEMERELLA; TREATMENT OUTCOME; VETERINARY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; DUCKS; FLAVOBACTERIACEAE INFECTIONS; GENE EXPRESSION PROFILING; OLIGODEOXYRIBONUCLEOTIDES; POULTRY DISEASES; RECOMBINANT PROTEINS; RIEMERELLA; TREATMENT OUTCOME; VACCINES, SUBUNIT;

EID: 84919338677     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.11.010     Document Type: Article

References (36)

1. Kardos G., Nagy J., Antal M., Bistyak A., Tenk M., Kiss I. Development of a novel PCR assay specific for Riemerella anatipestifer. Lett Appl Microbiol 2007, 44(2):145-148.
2. Sandhu T., Rimler R. Riemerella anatipestifer infection. Diseases of poultry 1997, Iowa State University Press, Ames /Mosby-Wolfe, London. 10th ed.
3. Chen Y.P., Tsao M.Y., Lee S.H., Chou C.H., Tsai H.J. Prevalence and molecular characterization of chloramphenicol resistance in Riemerella anatipestifer isolated from ducks and geese in Taiwan. Avian Pathol 2010, 39(5):333-338.
4. Chen Y.P., Lee S.H., Chou C.H., Tsai H.J. Detection of florfenicol resistance genes in Riemerella anatipestifer isolated from ducks and geese. Vet Microbiol 2012, 154(3-4):325-331.
5. Sun N., Liu J.H., Yang F., Lin D.C., Li G.H., Chen Z.L., et al. Molecular characterization of the antimicrobial resistance of Riemerella anatipestifer isolated from ducks. Vet Microbiol 2012, 158(3-4):376-383.
6. Sandhu T.S. Immunogenicity and safety of a live Pasteurella anatipestifer vaccine in White Pekin ducklings: laboratory and field trials. Avian Pathol 1991, 20(3):423-432.
7. Rubbenstroth D., Ryll M., Knobloch J.K., Kohler B., Rautenschlein S. Evaluation of different diagnostic tools for the detection and identification of Riemerella anatipestifer. Avian Pathol 2013, 42(1):17-26.
8. Sandhu T. Immunization of White Pekin ducklings against Pasteurella anatipestifer infection. Avian Dis 1979, 23(3):662-669.
9. Liu H., Wang X., Ding C., Han X., Cheng A., Wang S., et al. Development and evaluation of a trivalent Riemerella anatipestifer-inactivated vaccine. Clin Vaccine Immunol 2013, 20(5):691-697.
10. Pathanasophon P., Sawada T., Pramoolsinsap T., Tanticharoenyos T. Immunogenicity of Riemerella anatipestifer broth culture bacterin and cell-free culture filtrate in ducks. Avian Pathol 1996, 25(4):705-719.
11. Hu Q., Han X., Zhou X., Ding C., Zhu Y., Yu S. OmpA is a virulence factor of Riemerella anatipestifer. Vet Microbiol 2011, 150(3-4):278-283.
12. Subramaniam S., Huang B., Loh H., Kwang J., Tan H.M., Chua K.L., et al. Characterization of a predominant immunogenic outer membrane protein of Riemerella anatipestifer. Clin Diagn Lab Immunol 2000, 7(2):168-174.
13. Huang B., Subramaniam S., Frey J., Loh H., Tan H.M., Fernandez C.J., et al. Vaccination of ducks with recombinant outer membrane protein (OmpA) and a 41 kDa partial protein (P45N') of Riemerella anatipestifer. Vet Microbiol 2002, 84(3):219-230.
14. Zhai Z., Cheng L., Tang F., Lu Y., Shao J., Liu G., et al. Immunoproteomic identification of 11 novel immunoreactive proteins of Riemerella anatipestifer serotype 2. FEMS Immunol Med Microbiol 2012, 65(1):84-95.
15. Hu Q., Ding C., Tu J., Wang X., Han X., Duan Y., et al. Immunoproteomics analysis of whole cell bacterial proteins of Riemerella anatipestifer. Vet Microbiol 2012, 157(3-4):428-438.
16. Zhai Z., Li X., Xiao X., Yu J., Chen M., Yu Y., et al. Immunoproteomics selection of cross-protective vaccine candidates from Riemerella anatipestifer serotypes 1 and 2. Vet Microbiol 2013, 162(2-4):850-857.
17. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408(6813):740-745.
18. Byadgi O., Puteri D., Lee J.W., Chang T.C., Lee Y.H., Chu C.Y., et al. The effect of TLR9 agonist CpG oligodeoxynucleotides on the intestinal immune response of cobia (Rachycentron canadum). J Immunol Res 2014, 2014:273284.
19. Brownlie R., Zhu J., Allan B., Mutwiri G.K., Babiuk L.A., Potter A., et al. Chicken TLR21 acts as a functional homologue to mammalian TLR9 in the recognition of CpG oligodeoxynucleotides. Mol Immunol 2009, 46(15):3163-3170.
20. Keestra A.M., de Zoete M.R., Bouwman L.I., van Putten J.P. Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9. J Immunol 2010, 185(1):460-467.
21. Patel B.A., Gomis S., Dar A., Willson P.J., Babiuk L.A., Potter A., et al. Oligodeoxynucleotides containing CpG motifs (CpG-ODN) predominantly induce Th1-type immune response in neonatal chicks. Dev Comp Immunol 2008, 32(9):1041-1049.
22. Mutwiri G. TLR9 agonists: immune mechanisms and therapeutic potential in domestic animals. Vet Immunol Immunopathol 2012, 148(1-2):85-89.
23. Scheiermann J., Klinman D.M. Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer. Vaccine 2014.
24. Wang W., Singh M. Selection of adjuvants for enhanced vaccine potency. World J Vaccines 2011, 1:33-78.
25. Jurk M., Schulte B., Kritzler A., Noll B., Uhlmann E., Wader T., et al. C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level. Immunobiology 2004, 209(1-2):141-154.
26. Hartmann G., Krieg A.M. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol 2000, 164(2):944-953.
27. He H., Kogut M.H. CpG-ODN-induced nitric oxide production is mediated through clathrin-dependent endocytosis, endosomal maturation, and activation of PKC, MEK1/2 and p38 MAPK, and NF-kappaB pathways in avian macrophage cells (HD11). Cell Signal 2003, 15(10):911-917.
28. Chu C.Y., Lee S.C., Liu S.S., Lin Y.M., Shen P.C., Yu C., et al. Cytosine-phosphate-guanine oligodeoxynucleotides containing GACGTT motifs enhance the immune responses elicited by keyhole limpet hemocyanin antigen in dairy cattle. Nucleic Acid Ther 2011, 21(5):323-332.
29. Lee J.W., Lin Y.M., Yen T.Y., Yang W.J., Chu C.Y. CpG oligodeoxynucleotides containing GACGTT motifs enhance the immune responses elicited by a goose parvovirus vaccine in ducks. Vaccine 2010, 28(50):7956-7962.
30. Hung L.H., Tsai P.C., Wang C.H., Li S.L., Huang C.C., Lien Y.Y., et al. Immunoadjuvant efficacy of plasmids with multiple copies of a CpG motif coadministrated with avian influenza vaccine in chickens. Vaccine 2011, 29(29-30):4668-4675.
31. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29(9):e45.
32. Klinman D.M. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol 2004, 4(4):249-258.
33. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002, 20:709-760.
34. Asselin-Paturel C., Trinchieri G. Production of type I interferons: plasmacytoid dendritic cells and beyond. J Exp Med 2005, 202(4):461-465.
35. Diehl S., Rincon M. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 2002, 39(9):531-536.
36. Zhang Y., Shoda L.K., Brayton K.A., Estes D.M., Palmer G.H., Brown W.C. Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes, and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif. J Interferon Cytokine Res 2001, 21(10):871-881.